Recommendations about inclusion of two devices into French innovation package in April 2019

Jun 2019

In France, there is a fast-track pathway, which provides reimbursement within the framework of the prospective medico-economic study, aiming at demonstrating benefits to patients or reduction of expenditure of health care system. It is determined in the article L.165-1-1 of the Social Security Code and driven by the manufacturer. The manufacturer includes a protocol of the study in the submission dossier for authorities.

On the 19th of April, the French National Authority for Health (HAS) published two opinions regarding the inclusion of two devices into innovation package in France:

eCLIPS: a medical device for treatment of cerebral aneurysm
Nuvaira™ Lung Denervation System: a catheter-based system used to address chronic obstructive pulmonary disease (COPD) and asthma

Decisions should be made jointly by Ministry of Health and HAS. Innovation funding is granted on the basis of publication in the Official French Gazette (Journal Officiel de la République Française).

See the full information in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

NHS Insights Prioritisation Programme in England

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

2022 RIHN and Supplementary list for IVD tests published in France

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

The G-BA Innovation Committee recommends transfer to standard care for three projects in Germany

Mar 2022

On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.

Healthcare Implementation Communique updated in Turkey

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Treatment Council's symposium 2022 open for registration in Denmark

Mar 2022

On February 14, 2022, the Danish Treatment Council (Behandlingsråd), a new body for assessing treatments and health technologies that became fully operational in late May 2021, has announced its symposium, which will take place in Aalborg on May 11, 2022.